Status:
UNKNOWN
Fibrinogen to Albumin Ratio and C-reactive Protein to Albumin Ratio in Juvenile Idiopathic Arthritis
Lead Sponsor:
Assiut University
Conditions:
Juvenile Idiopathic Arthritis
Eligibility:
All Genders
Up to 16 years
Brief Summary
The fibrinogen to albumin ratio (FAR) and C-reactive protein to albumin ratio (CAR) have emerged as useful biomarkers to predict systemic inflammation. The aim here is to investigate the relation betw...
Detailed Description
The JADAS27 includes a selected count of the following joints: cervical spine, elbows, wrists, metacarpophalangeal joints (from first to third), proximal interphalangeal joints, hips, knees and ankles...
Eligibility Criteria
Inclusion
- All juvenile idiopathic arthritis fulfilling the criteria of International League of Associations for Rheumatology (ILAR) and age and sex matched healthy subjects
Exclusion
- Other systemic inflammatory or autoimmune disorders.
- History of corticosteroid medication in the last 6 months.
- Liver diseases.
- Malignancy.
Key Trial Info
Start Date :
November 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2024
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT06024486
Start Date
November 1 2023
End Date
July 1 2024
Last Update
October 6 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.